CompletedNCT00175513
Valacyclovir for symptoms of early psychosis
About this title
Read the official source — NCT00175513Medication studyAges 18–65CanadaSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Victoria and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00175513
- Official title
Show the full official title
V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Victoria · White Rock
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Did this study involve medication?
Yes. The study involved medication, including Valacyclovir (Valtrex).
Who was this study for?
Listed age limits: 18 years to 65 years.
